Published in BMC Pulm Med on December 29, 2009
The development and pilot testing of the self-management programme of activity, coping and education for chronic obstructive pulmonary disease (SPACE for COPD). Int J Chron Obstruct Pulmon Dis (2013) 0.95
Putting health status guided COPD management to the test: protocol of the MARCH study. BMC Pulm Med (2013) 0.89
RECODE: design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care. BMC Pulm Med (2013) 0.87
Detecting exacerbations using the Clinical COPD Questionnaire. Health Qual Life Outcomes (2010) 0.87
Recent advances in the management of breathlessness. Indian J Palliat Care (2011) 0.77
Consultation performance of general practitioners when supported by an asthma/COPDC-service. BMC Res Notes (2012) 0.75
Efficacy of a self-management plan in exacerbations for patients with advanced COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Barriers and facilitators influencing self-management among COPD patients: a mixed methods exploration in primary and affiliated specialist care. Int J Chron Obstruct Pulmon Dis (2016) 0.75
The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 10.05
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax (2002) 8.77
The St George's Respiratory Questionnaire. Respir Med (1991) 8.49
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med (1987) 8.41
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39
Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med (2003) 6.82
Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) Am J Respir Crit Care Med (1996) 5.82
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 5.49
Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 4.87
Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med (2000) 4.81
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med (2001) 4.48
Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes (2003) 4.41
Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J (2002) 3.92
Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics (2002) 3.70
Sample size in cluster randomisation. BMJ (1998) 2.82
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax (2004) 2.78
Modified informed consent procedure: consent to postponed information. BMJ (2003) 1.94
Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med (2007) 1.85
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials. Thorax (2007) 1.81
Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.54
(Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax (2009) 1.48
Action plans for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2005) 1.47
Promoting effective self-management programmes to improve COPD. Eur Respir J (2009) 1.39
Evaluation of a self-management plan for chronic obstructive pulmonary disease. Eur Respir J (1997) 1.18
Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J (2005) 1.10
Patients' evaluation of informed consent to postponed information: cohort study. BMJ (2004) 1.08
Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J (2005) 1.08
Self-management plans in the primary care of patients with chronic obstructive pulmonary disease. Respirology (2006) 0.99
Patient's preference and randomization: new paradigm of evidence-based clinical research. World J Surg (2005) 0.94
Multicenter randomized controlled trial of an outreach nursing support program for recently discharged stroke patients. Stroke (2004) 0.92
Reported and unreported exacerbations of COPD: analysis by diary cards. Chest (2007) 0.90
Written action plans in chronic obstructive pulmonary disease increase appropriate treatment for acute exacerbations. Respirology (2006) 0.88
The effects of additional care by a pulmonary nurse for asthma and COPD patients at a respiratory outpatient clinic: results from a double blind, randomized clinical trial. Patient Educ Couns (2007) 0.83
Management of lung nodules detected by volume CT scanning. N Engl J Med (2009) 6.79
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med (2015) 5.86
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2007) 5.51
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2008) 4.12
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J (2008) 3.67
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med (2012) 3.62
Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J (2005) 3.58
Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 3.58
Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med (2013) 3.47
Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med (2009) 3.43
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003. Can Respir J (2003) 3.14
FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol (2002) 2.86
How to assess physical activity? How to assess physical fitness? Eur J Cardiovasc Prev Rehabil (2005) 2.78
Lung function decline in male heavy smokers relates to baseline airflow obstruction severity. Chest (2012) 2.77
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2011) 2.38
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32
Physical activity and hospitalization for exacerbation of COPD. Chest (2006) 2.24
Effects of pulmonary rehabilitation in patients with restrictive lung diseases. Chest (2009) 2.22
Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J (2013) 2.20
CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax (2011) 2.20
Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med (2005) 2.11
Self-management programmes for COPD: moving forward. Chron Respir Dis (2012) 2.07
Reduced neonatal lung function and wheezing illnesses during the first 5 years of life. Eur Respir J (2012) 2.06
The effect of Helicopter Emergency Medical Services on trauma patient mortality in the Netherlands. Injury (2012) 2.01
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2009) 1.98
The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet (2006) 1.95
Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA (2011) 1.94
Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med (2008) 1.90
Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med (2011) 1.89
Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med (2007) 1.85
Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax (2011) 1.82
Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.78
Clinical efficacy of three common treatments in acute otitis externa in primary care: randomised controlled trial. BMJ (2003) 1.78
Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One (2012) 1.77
A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol (2005) 1.76
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2014) 1.72
Alternatives for randomization in lifestyle intervention studies in cancer patients were not better than conventional randomization. J Clin Epidemiol (2012) 1.71
Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Act (2012) 1.70
Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction. Atherosclerosis (2013) 1.69
Are patients with COPD more active after pulmonary rehabilitation? Chest (2008) 1.69
Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail (2006) 1.68
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention. COPD (2008) 1.65
Computed tomography-quantified emphysema distribution is associated with lung function decline. Eur Respir J (2012) 1.65
Results of surgical treatment of T4 non-small cell lung cancer. Eur J Cardiothorac Surg (2003) 1.65
Cohort profile: the EPIC-NL study. Int J Epidemiol (2009) 1.63
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum (2007) 1.63
A Canadian, multicentre, randomized clinical trial of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease: rationale and methods. Can Respir J (2005) 1.63
The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review. Fam Pract (2009) 1.62
Effectiveness of physician-targeted interventions to improve antibiotic use for respiratory tract infections. Br J Gen Pract (2012) 1.59
Prescribing antibiotics for respiratory tract infections by GPs: management and prescriber characteristics. Br J Gen Pract (2005) 1.58
Effects of written action plan adherence on COPD exacerbation recovery. Thorax (2010) 1.57
Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment. Can Respir J (2004) 1.55
Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J (2013) 1.53
Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality -- a systematic review. Respir Res (2005) 1.51
Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res (2011) 1.51
Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med (2002) 1.47
Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary care. Br J Gen Pract (2015) 1.45
Pain assessments at triage with the Manchester triage system: a prospective observational study. Emerg Med J (2010) 1.44
Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities. J Antimicrob Chemother (2004) 1.44
Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J (2013) 1.42
Effects of telemonitoring in patients with chronic obstructive pulmonary disease. Telemed J E Health (2008) 1.41
Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol (2007) 1.40
Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol (2006) 1.40
Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil (2005) 1.39
Physical Activity and Mortality in Individuals With Diabetes Mellitus: A Prospective Study and Meta-analysis. Arch Intern Med (2012) 1.38
Physical activity and endometrial cancer risk, a systematic review of current evidence. Cancer Epidemiol Biomarkers Prev (2007) 1.35
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J (2004) 1.35
European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care (2007) 1.32
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
Self-medication with antibiotics in Europe: a case for action. Curr Drug Saf (2010) 1.31
Patient safety culture measurement in general practice. Clinimetric properties of 'SCOPE'. BMC Fam Pract (2011) 1.30
Systemic corticosteroid monotherapy for clinically diagnosed acute rhinosinusitis: a randomized controlled trial. CMAJ (2012) 1.28
European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf (2011) 1.27
Determinants of antibiotic overprescribing in respiratory tract infections in general practice. J Antimicrob Chemother (2005) 1.27
Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Respir Med (2007) 1.27
Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res (2011) 1.27
Canadian Thoracic Society COPD Guidelines: summary of highlights for family doctors. Can Respir J (2003) 1.25
Outpatient antibiotic prescriptions from 1992 to 2001 in the Netherlands. J Antimicrob Chemother (2003) 1.25
Living with chronic obstructive pulmonary disease: a survey of patients' knowledge and attitudes. Respir Med (2009) 1.24